AEON Biopharma, Inc. Shares Issued
AEON Biopharma, Inc. (AEON) had Shares Issued of 26.31 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-12
- 2026-06-30: Common Stock, Shares, Issued 26.31M shares.
- 2026-03-31: Common Stock, Shares, Issued 25.30M shares.
- 2025-12-31: Common Stock, Shares, Issued 12.11M shares.
- 2025-09-30: Common Stock, Shares, Issued 11.64M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 26.31M shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 25.30M shares 10-Q · filed 2026-05-14 | |
| 2025-12-31 | 12.11M shares 10-Q · filed 2026-08-12 | |
| 2025-09-30 | 11.64M shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 11.54M shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 10.54M shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 555.51K shares 10-K · filed 2026-03-30 | |
| 2024-09-30 | 39.59M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 39.12M shares 10-Q · filed 2024-08-12 | |
| 2024-03-31 | 38.12M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 516.40K shares 10-K · filed 2025-03-24 | 37.16M shares 10-K · filed 2024-03-29 |
| 2023-09-30 | 37.16M shares 10-Q/A · filed 2024-03-29 | |
| 2022-12-31 | 138.85M shares 10-K · filed 2025-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |